Hantz Financial Services’s Jazz Pharmaceuticals JAZZ Stock Holding History
Bought
Maintained
Sold
Other funds holding JAZZ
VPM
VCM
EC
Hantz Financial Services's JAZZ Position: Q1 2026 in Review
Hantz Financial Services increased its Jazz Pharmaceuticals (JAZZ) stake by 42% in Q1 2026, buying an estimated $170K and bringing the position to 3,293 shares worth $623K. The position accounts for 0.01% of the portfolio, ranked #587.
Hantz Financial Services first reported a position in JAZZ in Q1 2020 and has held it in 21 quarters since. The position peaked at $3.02M in Q1 2020. 570 funds tracked by Wall St. Rank hold JAZZ as of Q1 2026.
- Hantz Financial Services held 3,293 shares of Jazz Pharmaceuticals worth $623K as of Q1 2026.
- Hantz Financial Services bought 973 Jazz Pharmaceuticals shares in Q1 2026, an estimated $170K.
- Jazz Pharmaceuticals made up 0.01% of Hantz Financial Services's portfolio in Q1 2026, its #587 holding.
- Hantz Financial Services first reported a position in Jazz Pharmaceuticals in Q1 2020 and has held it in 21 quarters since.
- Hantz Financial Services's Jazz Pharmaceuticals position peaked at $3.02M in Q1 2020.
- 570 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q1 2026.
Based on Hantz Financial Services's 13F filing for Q1 2026, filed 1 May 2026.